Progression‐free survival at 2 years post‐autologous transplant: a surrogate end point for overall survival in follicular lymphoma

Overall survival (OS) is the gold‐standard end point for studies evaluating autologous stem cell transplantation (ASCT) in follicular lymphoma (FL), but assessment may be elusive due to the lengthy disease course. We analyzed the validity of two earlier end points, proposed in the setting of first‐l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Med
Hauptverfasser: Jiménez‐Ubieto, Ana, Grande, Carlos, Caballero, Dolores, Yáñez, Lucrecia, Novelli, Silvana, Hernández, Miguel T., Manzanares, María, Arranz, Reyes, Ferreiro, José Javier, Bobillo, Sabela, Mercadal, Santiago, Galego, Andrea, Jiménez, Javier López, Moraleda, José María, Vallejo, Carlos, Albo, Carmen, Pérez, Elena, Marrero, Carmen, Magnano, Laura, Palomera, Luis, Jarque, Isidro, Coria, Erika, Rodriguez, Antonia, Martín, Alejandro, López‐Guillermo, Armando, Salar, Antonio, Lahuerta, Juan José
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2017
Schlagworte:
Clinical Cancer Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727300/
https://ncbi.nlm.nih.gov/pubmed/29076254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1217
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge